📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Immunservice

1.1 - Company Overview

Immunservice Logo

Immunservice

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of interleukin-2-based immunotherapy solutions, developing biomimetic medicines, vaccines, and growth factors, and offering IL-2 bioactivity measurements and resources for diagnostic and pharmaceutical development. Focuses on human and animal immunotherapy and human cell therapy, enhancing immune cell proliferation and targeting cancer and virus cells.

Products and services

  • Interleukin-2-Based Medicines: Immunservice develops biomimetic therapeutics based on interleukin-2 for market approval, targeting therapeutic applications in human and animal immunotherapy and human cell therapy
  • Interleukin-2: This natural immune hormone underpins development of medicines, vaccines, and growth factors, enhancing immune cell proliferation and targeting cancer and virus cells
  • Interleukin-2 Bioactivity Measurements: This specialized service offers bioactivity measurements of interleukin-2 to support research and development in diagnostic and pharmaceutical developments and other specialized applications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Immunservice

Argenx Logo

Argenx

HQ: United States Website
  • Description: Provider of immunology therapies for severe autoimmune diseases and cancer, including efgartigimod, an investigational antibody fragment targeting FcRn for severe autoimmune diseases with pathogenic IgG autoantibodies; ARGX-117, a humanized sweeping antibody inhibiting C2 and downstream complement in IgM-driven diseases; and empasiprubart, a human IgG1 anti-C2 sweeping antibody with enhanced FcRn binding to improve C2 clearance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Argenx company profile →
Outlook Therapeutics Logo

Outlook Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical development focused on ophthalmic formulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Outlook Therapeutics company profile →
Calypso Biotech Logo

Calypso Biotech

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical research and development focused on therapeutics for autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calypso Biotech company profile →
Intercell Logo

Intercell

HQ: Austria Website
  • Description: Provider of vaccine design and development for prevention and treatment of infectious diseases, leveraging proprietary technology platforms to discover and develop antigens and adjuvants. Founded in 1998 and headquartered in Vienna, Austria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intercell company profile →
MolMed Logo

MolMed

HQ: Italy Website
  • Description: Provider of medical biotechnology research, development and clinical validation of novel anticancer therapies. The pipeline includes antitumour therapeutics in clinical and preclinical development, including Zalmoxis (TK), a cell-based therapy enabling bone marrow transplants from partially compatible donors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MolMed company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Immunservice

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Immunservice

2.2 - Growth funds investing in similar companies to Immunservice

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Immunservice

4.2 - Public trading comparable groups for Immunservice

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Immunservice

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Immunservice

What does Immunservice do?

Immunservice is a provider of interleukin-2-based immunotherapy solutions, developing biomimetic medicines, vaccines, and growth factors, and offering IL-2 bioactivity measurements and resources for diagnostic and pharmaceutical development. Focuses on human and animal immunotherapy and human cell therapy, enhancing immune cell proliferation and targeting cancer and virus cells.

Who are Immunservice's competitors?

Immunservice's competitors and similar companies include Argenx, Outlook Therapeutics, Calypso Biotech, Intercell, and MolMed.

Where is Immunservice headquartered?

Immunservice is headquartered in Germany.

How many employees does Immunservice have?

Immunservice has 1,000 employees 🔒.

When was Immunservice founded?

Immunservice was founded in 2010 🔒.

What sector and industry vertical is Immunservice in?

Immunservice is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Immunservice

Who are the top strategic acquirers in Immunservice's sector and industry

Top strategic M&A buyers and acquirers in Immunservice's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Immunservice?

Top strategic M&A buyers groups and sectors for Immunservice include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Immunservice's sector and industry vertical

Which are the top PE firms investing in Immunservice's sector and industry vertical?

Top PE firms investing in Immunservice's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Immunservice's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Immunservice's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Immunservice's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Immunservice include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Immunservice's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Immunservice?

The key public trading comparables and valuation benchmarks for Immunservice include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Immunservice for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Immunservice with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Immunservice's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Immunservice with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Immunservice's' sector and industry vertical?

Access recent funding rounds and capital raises in Immunservice's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Immunservice

Launch login modal Launch register modal